Intelligence · Clinical pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
Pipeline programs
-
BULEVIRTIDE, BJT-778
Blue Earth Diagnostics Ireland Ltd
Chronic Hepatitis D Infection
1 trial -
BULEVIRTIDE, BJT-778
Blue Earth Diagnostics Ireland Ltd
Chronic Hepatitis D Infection
1 trial -
BX44273
Hoffmann-La Roche
This is an extension study designed to provide continued treatment for eligible patients with cancer who were previously enrolled and treated in a Genentech/Roche study (the parent study), and do not have access to the treatment locally
1 trial -
BXCL501
BioXcel Therapeutics
Agitation,Psychomotor
1 trial -
BXCL501
BioXcel Therapeutics
Agitation
4 trials -
Bacillus Calmette Guerin and interferon alpha
Hospital Authority, Hong Kong
Carcinoma of Urinary Bladder, Superficial
1 trial -
BaidI Quzhi granule
Universal Integrated
Acne Vulgaris
1 trial -
Baloxavir Marboxil
Hoffmann-La Roche
Influenza
1 trial -
Balugrastim
Teva Pharma GmbH
Chemotherapy-induced Neutropenia
1 trial -
Bardoxolone methyl
Biogen
Pulmonary Hypertension
1 trial -
Baricitinib
Eli Lilly Co.
Covid19 Corona Virus Infection
1 trial -
Baricitinib
Eli Lilly and Company
Systemic Lupus Erythematosus
1 trial -
Baricitinib
Eli Lilly and Company
Systemic Juvenile Idiopathic Arthritis
1 trial -
Barley beta-glucan(3.0g)
Hospital Authority, Hong Kong
Overweight; Hyperlipidemia
1 trial -
Bavencio 20 mg/mL concentrate for solution for infusion
Merck Sharp and Dohme
Solid Tumors
1 trial -
BaxHTN / D6970C00002
AstraZeneca AB
Uncontrolled hypertension (uTHN) defined as blood pressure that remains higher than goal levels despite patients being treated with 2 anti-hypertensive agents, including a diuretic. Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.
1 trial -
Baxdrostat
AstraZeneca
Uncontrolled Hypertension
2 trials -
Baxdrostat
AstraZeneca
Primary Hyperaldosteronism
1 trial -
Baxdrostat, Baxdrostat Placebo
AstraZeneca AB
Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.
1 trial -
Beclomethasone Dipropionate 640
Teva Pharma GmbH
Persistent Asthma
1 trial -
Beclomethasone dipropionate
Teva Pharma GmbH
Asthma
2 trials -
Beclomethasone dipropionate
Teva Pharma GmbH
Seasonal Allergic Rhinitis
1 trial -
Beclomethasone dipropionate
Teva Pharma GmbH
Rhinitis, Allergic, Perennial
1 trial -
Beclomethasone dipropionate BAI
Teva Pharma GmbH
Asthma
1 trial -
Beclomethasone dipropionate breath-actuated inhaler
Teva Pharma GmbH
Persistent Asthma
1 trial -
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol
Teva Pharma GmbH
Rhinitis, Allergic, Perennial
1 trial -
Bedaquiline
BRIGHT MINDS BIOSCIENCES INC.
Multi-drug Resistant Tuberculosis
1 trial -
Bedaquiline (B)
The First People's Hospital of Lianyungang
Pulmonary Tuberculosis
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
3 trials -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Abuse
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Behavior Therapy
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
HCV Negative Status
1 trial -
Behavior therapy
United Therapeutics Europe Ltd
Autism Spectrum Disorder
1 trial -
Behavioral Drug and HIV Risk Reduction Counseling
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
Bel-sar
Aura Biosciences
Choroidal Melanoma
1 trial -
Belantamab mafodotin
GlaxoSmithKline
Multiple Myeloma
1 trial -
Bemnifosbuvir (BEM)
Atea Pharmaceuticals
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
1 trial -
Bemnifosbuvir-Ruzasvir
Atea Pharmaceuticals
HEPATITIS C VIRUS CHRONIC INFECTION
1 trial -
Bemnifosbuvir-Ruzasvir (BEM/RZR)
Atea Pharmaceuticals
HEPATITIS C VIRUS CHRONIC INFECTION
1 trial -
Bempedoic Acid + Ezetimibe Fixed-Dose Combination
Esperion Therapeutics
Hyperlipidemias
1 trial -
Bempedoic acid 180 mg tablet
Esperion Therapeutics
Cardiovascular Diseases
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Melanoma
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Metastatic Head and Neck Cancer
1 trial -
Bendamustine
Hoffmann-La Roche
Chronic Lymphocytic Leukemia
1 trial -
Bendamustine HCl
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
1 trial -
Bendamustine hydrochloride
Teva Pharma GmbH
Non-Hodgkin Lymphoma
1 trial -
Benlysta 200 mg solution for injection in pre-filled pen.
GlaxoSmithKline
connective tissue diseases
1 trial -
Benralizumab
AstraZeneca
Chronic Obstructive Pulmonary Disease
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.